Literature DB >> 25932757

Revisiting "Good" and "Bad" Cholesterol. The Battle over Flow through Arteries Now Shifts to Flow through Airways.

Michael B Fessler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25932757      PMCID： PMC4435461          DOI： 10.1164/rccm.201502-0413ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  21 in total

Review 1.  Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges.

Authors:  Robert S Rosenson; H Bryan Brewer; Benjamin Ansell; Philip Barter; M John Chapman; Jay W Heinecke; Anatol Kontush; Alan R Tall; Nancy R Webb
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

2.  Lipoprotein-stimulated surfactant secretion in alveolar type II cells: mediation by heterotrimeric G proteins.

Authors:  M S Pian; L G Dobbs
Journal:  Am J Physiol       Date:  1997-09

Review 3.  HDL and cardiovascular disease.

Authors:  Daniel J Rader; G Kees Hovingh
Journal:  Lancet       Date:  2014-08-16       Impact factor: 79.321

Review 4.  HDL-targeted therapies: progress, failures and future.

Authors:  Bronwyn A Kingwell; M John Chapman; Anatol Kontush; Norman E Miller
Journal:  Nat Rev Drug Discov       Date:  2014-05-23       Impact factor: 84.694

Review 5.  The role of advanced lipid testing in the prediction of cardiovascular disease.

Authors:  Alvin Chandra; Anand Rohatgi
Journal:  Curr Atheroscler Rep       Date:  2014-03       Impact factor: 5.113

Review 6.  High-density lipoproteins: a consensus statement from the National Lipid Association.

Authors:  Peter P Toth; Philip J Barter; Robert S Rosenson; William E Boden; M John Chapman; Marina Cuchel; Ralph B D'Agostino; Michael H Davidson; W Sean Davidson; Jay W Heinecke; Richard H Karas; Anatol Kontush; Ronald M Krauss; Michael Miller; Daniel J Rader
Journal:  J Clin Lipidol       Date:  2013-08-11       Impact factor: 4.766

7.  Next stop for HDL: the lung.

Authors:  M B Fessler
Journal:  Clin Exp Allergy       Date:  2012-03       Impact factor: 5.018

8.  HDL is the major source of vitamin E for type II pneumocytes.

Authors:  I Kolleck; M Schlame; H Fechner; A C Looman; H Wissel; B Rüstow
Journal:  Free Radic Biol Med       Date:  1999-10       Impact factor: 7.376

9.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

10.  High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3.

Authors:  Dominic De Nardo; Larisa I Labzin; Hajime Kono; Reiko Seki; Susanne V Schmidt; Marc Beyer; Dakang Xu; Sebastian Zimmer; Catharina Lahrmann; Frank A Schildberg; Johanna Vogelhuber; Michael Kraut; Thomas Ulas; Anja Kerksiek; Wolfgang Krebs; Niklas Bode; Alena Grebe; Michael L Fitzgerald; Nicholas J Hernandez; Bryan R G Williams; Percy Knolle; Manfred Kneilling; Martin Röcken; Dieter Lütjohann; Samuel D Wright; Joachim L Schultze; Eicke Latz
Journal:  Nat Immunol       Date:  2013-12-08       Impact factor: 25.606
View more
  2 in total

1.  High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics.

Authors:  Amisha V Barochia; Elizabeth M Gordon; Maryann Kaler; Rosemarie A Cuento; Patricia Theard; Debbie M Figueroa; Xianglan Yao; Nargues A Weir; Maureen L Sampson; Mario Stylianou; David F Choy; Cecile T J Holweg; Alan T Remaley; Stewart J Levine
Journal:  J Lipid Res       Date:  2017-06-27       Impact factor: 5.922

Review 2.  Emerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and Mechanisms.

Authors:  Hannu Kankaanranta; Paula Kauppi; Leena E Tuomisto; Pinja Ilmarinen
Journal:  Mediators Inflamm       Date:  2016-04-26       Impact factor: 4.711
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.